Loading...
Indivior PLC
INDV.L•LSE
Healthcare
Drug Manufacturers - Specialty & Generic
£1238.00
£19.00(1.56%)
Indivior PLC (INDV.L) Financial Performance & Income Statement Overview
Review Indivior PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.69%
↑ 8.69%
Operating Income Growth
900.00%
↑ 900.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
111.43%
↑ 111.43%
Operating Margin
2.90%
↑ 2.90%
Gross Margin
80.44%
↑ 80.44%
Net Profit Margin
0.26%
↑ 0.26%
ROE
-1.30%
↓ 1.30%
ROIC
9.19%
↑ 9.19%
Indivior PLC (INDV.L) Income Statement & Financial Overview
Review Indivior PLC's (INDV.L) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $266.00M | $299.00M | $307.00M | $299.61M |
| Cost of Revenue | $44.00M | $23.00M | $69.00M | $116.24M |
| Gross Profit | $222.00M | $276.00M | $238.00M | $183.37M |
| Gross Profit Ratio | $0.83 | $0.92 | $0.78 | $0.61 |
| R&D Expenses | $22.00M | $31.00M | $22.63M | $27.05M |
| SG&A Expenses | $132.00M | -$47.00M | $208.00M | $311.00M |
| Operating Expenses | $156.00M | $180.00M | $234.00M | $148.30M |
| Total Costs & Expenses | $200.00M | $203.00M | $303.00M | $264.54M |
| Interest Income | $4.00M | $5.00M | $5.00M | $6.00M |
| Interest Expense | $12.00M | $13.00M | $10.00M | $9.00M |
| Depreciation & Amortization | $5.00M | $5.00M | -$10.00M | $25.05M |
| EBITDA | $76.00M | $106.00M | $9.00M | -$101.21M |
| EBITDA Ratio | $0.29 | $0.35 | $0.03 | -$0.34 |
| Operating Income | $66.00M | $96.00M | $4.00M | $35.07M |
| Operating Income Ratio | $0.25 | $0.32 | $0.01 | $0.12 |
| Other Income/Expenses (Net) | -$7.00M | -$8.00M | -$5.00M | -$3.00M |
| Income Before Tax | $59.00M | $88.00M | -$1.00M | -$135.27M |
| Income Before Tax Ratio | $0.22 | $0.29 | -$0.003 | -$0.45 |
| Income Tax Expense | $11.00M | $28.00M | -$5.00M | -$28.06M |
| Net Income | $47.00M | $59.00M | $4.00M | -$107.22M |
| Net Income Ratio | $0.18 | $0.20 | $0.01 | -$0.36 |
| EPS | $0.38 | $0.45 | $0.03 | -$0.80 |
| Diluted EPS | $0.38 | $0.44 | $0.03 | -$0.80 |
| Weighted Avg Shares Outstanding | $123.68M | $126.61M | $132.10M | $134.85M |
| Weighted Avg Shares Outstanding (Diluted) | $123.68M | $128.08M | $133.55M | $134.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan